Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNexus Gene Lab (BGLC) Work In Process (2024 - 2025)

Historic Work In Process for BioNexus Gene Lab (BGLC) over the last 2 years, with Q3 2025 value amounting to $190588.0.

  • BioNexus Gene Lab's Work In Process changed N/A to $190588.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $190588.0, marking a year-over-year change of. This contributed to the annual value of $188797.0 for FY2024, which is N/A changed from last year.
  • Per BioNexus Gene Lab's latest filing, its Work In Process stood at $190588.0 for Q3 2025.
  • BioNexus Gene Lab's 5-year Work In Process high stood at $190588.0 for Q3 2025, and its period low was $188797.0 during Q4 2024.